SCHEMBL3232013

SCHEMBL3232013

CCCC(=O)c1cc(C#N)c(OCc2ccccc2)nc1COCc1ccc(OC)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
APP P05067 1/20 0.41
P2RY12 Q9H244 2/20 0.40
XDH P47989 3/20 0.39
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231923 0.90 KDM4E (0.45) SMN1; SMN2HPGDNPC1RAB9AKDM4E
SCHEMBL3227733 0.89 KDM4E (0.43) SMN1; SMN2HPGDNPC1RAB9AKDM4E
SCHEMBL3226903 0.88 KDM4E (0.54) SMN1; SMN2HPGDKDM4EALDH1A1GLA
SCHEMBL3229431 0.77 P2RY12 (0.52) HPGDKDM4EALDH1A1GAAMAPT
SCHEMBL3941050 0.76 SMN1; SMN2 (0.39) SMN1; SMN2HPGDNPC1RAB9AKDM4E
SCHEMBL9449258 0.74 CNR1 (0.47) L3MBTL1XDHCNR1
SCHEMBL3234070 0.73 EPHX2 (0.38) SMN1; SMN2HPGDKDM4EALDH1A1GAA
SCHEMBL3330291 0.73 KDM4E (0.48) SMN1; SMN2HPGDKDM4EALDH1A1GAA
SCHEMBL3239377 0.73 P2RY12 (0.48) HPGDKDM4EALDH1A1GAAMAPT
SCHEMBL9846091 0.69 ALDH1A1 (0.53) SMN1; SMN2HPGDKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005384-A1 KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS ASTRAZENECA AB (SE) 2010-01-14 WO disclosed